Cargando...
Prostacyclin for pulmonary arterial hypertension
BACKGROUND: Pulmonary arterial hypertension (PAH) is characterised by pulmonary vascular changes, leads to elevated pulmonary artery pressures, dyspnoea, a reduction in exercise tolerance, right heart failure, and ultimately death. Prostacyclin analogue drugs mimic endogenous prostacyclin which lead...
Gardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2019
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6492481/ https://ncbi.nlm.nih.gov/pubmed/31042010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012785.pub2 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|